Demirci, U. Et Al. 2022. CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study. Journal of Hematopathology , vol.15, no.4 , 203-213.

Demirci, U., Kırkızlar, H. O., Ümit, E. G., Gürsoy, V., Pınar, İ. E., Özkalemkaş, F., ... Güven, Z. T.(2022). CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study. Journal of Hematopathology , vol.15, no.4, 203-213.

Demirci, Ufuk Et Al. "CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study," Journal of Hematopathology , vol.15, no.4, 203-213, 2022

Demirci, Ufuk Et Al. "CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study." Journal of Hematopathology , vol.15, no.4, pp.203-213, 2022

Demirci, U. Et Al. (2022) . "CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study." Journal of Hematopathology , vol.15, no.4, pp.203-213.

@article{article, author={Ufuk Demirci Et Al. }, title={CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study}, journal={Journal of Hematopathology}, year=2022, pages={203-213} }